Antibody responses after dose-sparing intradermal influenza vaccination

Vaccine

Volumn 25, Issue 4, 2007, Pages 659-663

  Auewarakul, Prasert ^a   Kositanont, Uraiwan ^a   Sornsathapornkul, Pornchai ^a   Tothong, Paichit ^a   Kanyok, Raweewan ^a   Thongcharoen, Prasert ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Antibody; Hemagglutination inhibition; Immune response; Influenza vaccine; Intradermal

Indexed keywords

INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CHILL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ERYTHEMA; FEMALE; FEVER; GEOMETRY; HEADACHE; HEMAGGLUTINATION INHIBITION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA AND VOMITING; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SKIN INDURATION; SKIN TEMPERATURE; TITRIMETRY; VACCINATION; VIRION; VIRUS STRAIN;

ADULT; ANTIBODIES, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; VACCINATION;

EID: 33845185901     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.08.026     Document Type: Article

References (10)

1. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 (2004) 2286-2294
2. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351 (2004) 2295-2301
3. Germann T.C., Kadau K., Longini Jr. I.M., and Macken C.A. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA 103 (2006) 5935-5940
4. Glenn G.M., Kenney R.T., Ellingsworth L.R., Frech S.A., Hammond S.A., and Zoeteweij J.P. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines 2 (2003) 253-267
5. Kamoltham T., Khawplod P., and Wilde H. Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine. Vaccine 20 (2002) 3272-3276
6. Khawplod P., Wilde H., Sirikwin S., Benjawongkulchai M., Limusanno S., Jaijaroensab W., et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 24 (2006) 3084-3086
7. Braddick M.R. Intradermal hepatitis B vaccine. Lancet 1 (1989) 957-958
8. Redfield R.R., Innis B.L., Scott R.M., Cannon H.G., and Bancroft W.H. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA 254 (1985) 3203-3206
9. Wistrom J. Intramuscular vs. intradermal hepatitis B vaccination: a 6-year follow-up. JAMA 273 (1995) 1835-1836
10. Harmon M.W., and Kendal A.P. Influenza viruses. In: Schmidt N.J., and Emmons R.W. (Eds). Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. (1989), American Public Health Association, Inc., Washington 631-668